BIO Protocol's CEO, Paul Kohlhaas, has announced that the BIO token will be launched on both the Solana blockchain and Ethereum. This launch is expected to happen soon and is a significant milestone for the decentralized biotechnology protocol.
Kohlhaas also mentioned plans for airdrops targeting specific communities, including Big Pharma, as a strategic move to engage with important industry players.
The BIO Protocol has successfully raised substantial funds through community financing, with $6.22 million in the first round, $11.14 million in the second round, and $2.9 million in a subsequent round, demonstrating strong investor interest and support for their initiatives.